Trial · NCT03191188
A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients
NCT03191188, Not applicable, Unknown, University of California, Irvine
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients. Trials, record NCT03191188. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03191188
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients
- NCT number
- NCT03191188
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 96 participants, estimated
- Lead sponsor
- University of California, Irvine
- Conditions
- Thyroid Disease, Kidney Diseases, Chronic
- Interventions
- Levothyroxine Sodium, Placebo Oral Tablet
- First posted
- 2017-06-19
- Last updated
- 2021-06-14
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Achievement of target TSH levels: serum TSH levels ranging from 0.5-3.0mIU/L | 12 weeks | Number of patients achieving target TSH levels of 0.5-3.0mIU/L |
| Secondary | Health-related quality of life Short Form 36 questionnaire | Baseline and 12 weeks | Change in Short Form 36 score |
| Secondary | Serum Growth Differentiation Factor 15 (GDF15) level | Baseline and 12 weeks | Change in GDF15 level |
| Secondary | Serum soluble p-selectin level | Baseline and 12 weeks | Change in soluble p-selectin level |
| Secondary | Serum soluble CD40 ligand level | Baseline and 12 weeks | Change in serum soluble CD40 ligand level |
| Secondary | Body mass index | Baseline and 12 weeks | Change in body mass index |
| Secondary | Biceps skinfold | Baseline and 12 weeks | Change in biceps skinfold |
| Secondary | Triceps skinfold | Baseline and 12 weeks | Change in triceps skinfold |
| Secondary | Mid-arm circumference | Baseline and 12 weeks | Change in mid-arm circumference |
| Secondary | Mid-arm muscle circumference | Baseline and 12 weeks | Change in mid-arm muscle circumference |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R03DK114642 | A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients | RHEE, CONNIE MEEYOUNG | UNIVERSITY OF CALIFORNIA-IRVINE | NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES | 2017 to 2018 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03191188
GET https://conductscience.org/api/trials/v1/NCT03191188/registered